0%
Skip to content

Stay in Touch

+44 (0)20 3747 5700

ContactUs@KesterCapital.com

14-16 Bruton Place

London

W1J 6LX

Portfolio

/

Avania

A vision to create the leading global medtech CRO

Sector

Life Sciences

Date

2016

Status

Prior

Watch

Kester partnered with Avania over 6 years to create a global CRO focused on the medtech sector. By 2022 we had achieved our goal of creating the leading, pure play medtech CRO.


Avania is the leading medtech CRO with offices in the US, Europe and AsiaPac. It supports global medtech OEMs to bring their products to market faster and more efficiently, working across a range of therapeutic areas including cardiovascular, orthopaedics, neurology, urology and aesthetics.

Avania offers full service clinical trial support covering strategic consulting, product development, data and biostats, clinical operations and market access and reimbursement. Long-term market growth is supported by increasing R&D investment, increased regulation and adoption of outsourcing.

How we created lasting value

Building a global platform through organic growth and strategic acquisitions

By accelerating organic growth and successfully completing four strategic acquisitions, we were able to establish a global presence

Assembling a global C-suite management team

We supported the business in hiring a complete C-suite team to professionalise operations and facilitate faster growth

Investing in the business infrastructure to support rapid scaling

We implemented the key technology and business infrastructure required to create a global platform out of regionally focused parts

other stats


Next case study:

Optibrium